Chimpanzees and Respiratory Synctial Virus and Palivizumab

 

                                                          Respiratory Synctial Virus

 

 

 

 

 

History Of Respiratory Synctial Virus

 

 

                                       Respiratory Synctial Virus Isolated From Chimpanzees

 

 

 

Robert Chanok Characterizes Respiratory Synctial Virus 

 

 

 

 

1998: FDA Approves Palivizumab

 

Humanised Monoclonal Antibody To Prevent RSV

 

 

 

 

 

 

Palivizumab: Mechanism Of Action

 

 

 

 Synagis Cost

 

 

 

 

 

Snapshot